- Home
- CGNT vs MGTX Comparison
CGNT vs MGTX Comparison
Compare CGNT & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$8.86
N/A
Current Price
$7.38
Company Overview
Basic Information| Metric | CGNT | MGTX |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.2M | 610.1M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CGNT | MGTX |
|---|---|---|
| Price | $8.86 | $7.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $13.50 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 468.3K | 295.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,279,000.00 |
| Revenue This Year | $16.36 | N/A |
| Revenue Next Year | $10.86 | $569.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 137.42 |
| 52 Week Low | $6.29 | $4.73 |
| 52 Week High | $11.66 | $9.73 |
Technical Indicators
Market Signals| Indicator | CGNT | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 46.57 |
| Support Level | $8.84 | $7.23 |
| Resistance Level | $9.77 | $7.50 |
| Average True Range (ATR) | 0.37 | 0.34 |
| MACD | 0.30 | -0.04 |
| Stochastic Oscillator | 98.11 | 55.22 |
Price Performance
Historical Comparison CGNT
MGTX
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.